Novartis has received approval from the U.S. Food and Drug Administration for it...
FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann
Beovu injections are used to treat wet age-related macular degeneration, a condition which can eventually lead to blindness and affects around 20 million people worldwide, the company said. In a highly competitive market Beovu will compete with Lucentis, Bayer’s Eylea and a new product that Novartis rival Roche has under development.
Frequent injections are a major reason why patients stop treating the condition, which is caused by abnormal blood vessels forming in the eye and leaking fluid, damaging part of the retina.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
US blacklists 28 Chinese entities over abuses in XinjiangUS blacklists over two dozen Chinese tech companies that develop facial recognition and other AI technology that the US says is being used to repress China's Muslim minority groups
続きを読む »
Trump's updated China blacklist slams shares of chipmaker AmbarellaAmbarella is getting wrapped up in the U.S.-China trade war as one of its customers, surveillance video company Hikvision, gets blacklisted.
続きを読む »
Box Office: 'Joker' Gets the Last Laugh With Record $93.5M U.S. BowThe edgy R-rated pic exceeded expectations despite heightened security at theaters across the country.
続きを読む »
‘Toxic Beauty’ Documentary at ‘Meet the Press’ Film Festival Highlights Lack of Cosmetics Regulations in the U.S.‘Toxic Beauty’ documentary at ‘Meet the Press’ film festival highlights lack of cosmetics regulations in the U.S.
続きを読む »
ten insane beauty accounts you need to follow on instagramJust some casual looks to pop to Tesco in.
続きを読む »